Related Experiment Video
Updated: Sep 3, 2025

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Metabolic Comorbidities and Cardiovascular Disease in Pediatric Psoriasis: A Narrative Review
Andrea Marani1, Giulio Rizzetto1, Giulia Radi1
1Clinic of Dermatology, Department of Clinical and Molecular Sciences, Polytechnic University of Marche, 60121 Ancona, Italy.
Insights
Pediatric psoriasis patients often experience metabolic issues like obesity and insulin resistance. Early awareness and tailored treatment are crucial for managing these associated health conditions in children.
Area of Science:
- Dermatology
- Pediatrics
- Metabolic Syndrome
Background:
- Psoriasis vulgaris is a chronic inflammatory skin condition.
- It is increasingly recognized as a systemic disease with significant comorbidities.
- Metabolic comorbidities are particularly prevalent in children with psoriasis.
Purpose of the Study:
- To review and synthesize current knowledge on metabolic comorbidities in pediatric psoriasis.
- To highlight the key metabolic health issues affecting children with this condition.
Main Methods:
- This study employed a narrative review approach.
- It synthesized existing literature on metabolic comorbidities in psoriatic children.
Main Results:
- Obesity is a primary metabolic comorbidity in children with psoriasis.
- Insulin resistance and type 2 diabetes are frequently observed.
- Cardiovascular disease and dyslipidemia are also significant concerns.
Conclusions:
- Dermatologists must recognize and actively manage metabolic comorbidities in pediatric psoriasis patients.
- Therapeutic strategies should be individualized based on the patient's overall clinical status.
- Addressing metabolic health is integral to comprehensive psoriasis care in children.
Abstract:
Psoriasis vulgaris is a common inflammatory, immune mediated, chronic recurrent dermatosis. Psoriasis is also a systemic inflammatory disease, associated with numerous comorbidities, particularly metabolic ones. Here, we summarize and discuss, in a narrative review, the current knowledge about the metabolic comorbidities in psoriatic children. Obesity, insulin resistance, diabetes, cardiovascular disease, and dyslipidemia are identified as the main comorbidities in psoriatic children. In conclusion, dermatologists should be aware of the metabolic comorbidities in children with psoriasis, modulating the therapeutic approach according to the patient's clinical condition.
More Related Videos
09:40Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
Published on: January 19, 2017
06:04Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Coronary Artery Disease I: Introduction
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies